Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Possibilities and problems of immunologic intervention in cancer.

× No keyword cloud information.

14 in total

Review 1. Recurrent and metastatic malignant disease: immunological considerations.

Authors: R L Carter
Journal: Proc R Soc Med Date: 1974-09

2. Antigens of carcinoma of the cervix uteri. A study by means of immunofluorescence.

Authors: D S Nelson
Journal: Clin Exp Immunol Date: 1974-01 Impact factor: 4.330

Review 3. Infectious diseases: annual review of significant publications.

Authors: H A Reimann
Journal: Postgrad Med J Date: 1973-05 Impact factor: 2.401

4. In vitro studies of lymphocytes from patients with plasma cell myeloma. I. Stimulation by mitogens and cytotoxic activities.

Authors: H Mellstedt; G Holm
Journal: Clin Exp Immunol Date: 1973-11 Impact factor: 4.330

5. Effects of acetaminophen on normal human peripheral blood lymphocytes: enhancement of mitogen- and antigen-stimulated incorporation of tritiated thymidine.

Authors: R S Panush; S J Ossakow
Journal: Clin Exp Immunol Date: 1979-12 Impact factor: 4.330

6. Adjuvant treatment of colorectal cancer.

Authors: J S Nystrom; J R Bateman; J Weiner
Journal: West J Med Date: 1977-02

7. Immunological competence in non-human primates: differences observed in four species.

Authors: J S Harvey; P J Felsburg; R L Heberling; W T Kniker; S S Kalter
Journal: Clin Exp Immunol Date: 1974-02 Impact factor: 4.330

8. Efficacy of streptococcal preparation OK-432 for gastric cancer patients--comparison between intradermal and intramuscular injection.

Authors: H Hanaue; T Kurosawa; S Yoshizaki; J Shikata
Journal: Jpn J Surg Date: 1984-05

9. Post operative stimulation of cell mediated immunity.

Authors: J A Smith; W S Hendry; J L Duncan; J N Norman
Journal: Klin Wochenschr Date: 1985-10-01

10. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.

Authors: A S Levin; V S Byers; H H Fudenberg; J Wybran; A J Hackett; J O Johnston; L E Spitler
Journal: J Clin Invest Date: 1975-03 Impact factor: 14.808